ESC Premium Access

Improving outcomes with non-vitamin K antagonist oral anticoagulants (NOACs): Focus on atrial fibrillation patients with acute coronary syndrome (ACS) and/or undergoing percutaneous coronary intervention (PCI)

Event: ESC CONGRESS 2019
Topic: Atrial Fibrillation (AF)
Session type: Satellite Symposium
Sponsored by The Bristol-Myers Squibb/Pfizer Alliance
Date: 3 September 2019
Time: 13:00 - 14:00

Session

5 presentations in this session

Achievements with NOACs in NVAF to date

Speaker: Professor M. Gilard (Brest, FR)
Thumbnail

NOACs in atrial fibrillation: Current landscape in clinical practice

Speaker: Professor N. Danchin (Paris, FR)
Thumbnail

Exploring evidence for long-standing questions

Speaker: Professor R. Lopes (Durham, US)
Thumbnail

Management of atrial fibrillation patients with concomitant need for antiplatelet therapy: Is the dilemma resolved?

Speaker: Professor P. Sinnaeve (Leuven, BE)
Thumbnail

Questions and answers

Speaker: Professor M. Gilard (Brest, FR)
Speaker: Professor R. Lopes (Durham, US)
Thumbnail

6 speakers from this session

Professor Martine Gilard

Hospital Cavale Blanche, Brest (France)
18 presentations
1 follower

Professor Nicolas Danchin

AP-HP - European Hospital Georges Pompidou, Paris (France)
13 presentations
0 follower

Professor Renato Lopes

Duke University Medical Center, Duke Clinical Research Institute, Durham (United States of America)
16 presentations
0 follower

Professor Peter R Sinnaeve

University Hospitals (UZ) Leuven, Campus Gasthuisberg, Department of Cardiology , Leuven (Belgium)
6 presentations
0 follower

Professor Martine Gilard

Hospital Cavale Blanche, Brest (France)
18 presentations
1 follower

Professor Renato Lopes

Duke University Medical Center, Duke Clinical Research Institute, Durham (United States of America)
16 presentations
0 follower

This platform is supported by

logo Novo Nordisk